PRKAA2 and cancer: Moreover, by phosphorylating Beclin-1 at Ser90/93/96, PRKAA/AMPKα boosts the assembly of the Beclin-1-SLC7A11 complex, inhibits system xc−, and stimulates the resulting ferroptotic demise of cancer cells (311).